Published in Clin Endocrinol (Oxf) on June 01, 2011
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension (2013) 1.55
Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study. PLoS One (2015) 1.39
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab (2012) 0.97
The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol (2011) 0.97
Can vitamin D slow down the progression of chronic kidney disease? Pediatr Nephrol (2011) 0.90
Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens (2013) 0.89
The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J Hum Hypertens (2015) 0.85
Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes. PLoS One (2012) 0.82
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes (2014) 0.80
Vitamin D and insulin sensitivity: can gene association and pharmacogenetic studies of the vitamin D receptor provide clarity? Metabolism (2012) 0.79
Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord (2013) 0.79
Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure. J Cardiovasc Pharmacol Ther (2014) 0.78
Vitamin D and cardio-metabolic disease. Metabolism (2013) 0.78
Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr) (2012) 0.75
Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals. J Hum Hypertens (2014) 0.75
The association between vitamin D receptor gene polymorphisms (TaqI and FokI), Type 2 diabetes, and micro-/macrovascular complications in postmenopausal women. Appl Clin Genet (2016) 0.75
Role of Vitamin D in Cardiovascular Diseases. Endocrinol Metab Clin North Am (2017) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 9.50
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet (2010) 7.69
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Genetics and biology of vitamin D receptor polymorphisms. Gene (2004) 4.60
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61
Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int (2008) 2.59
A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res (1997) 2.46
Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol (2010) 2.14
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Vitamin D and hypertension: current evidence and future directions. Hypertension (2010) 1.95
A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol (2010) 1.92
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res (2009) 1.90
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (2010) 1.69
Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev (2000) 1.68
The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol (2000) 1.58
Aldosterone--villain or bystander? N Engl J Med (2004) 1.49
Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta (2010) 1.46
Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer (2009) 1.42
Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) (2000) 1.30
Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney Int (2008) 1.28
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension (1998) 1.25
The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res (1998) 1.23
25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst (2011) 1.13
A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens (2010) 1.12
Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res (1999) 1.09
Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res (2005) 1.08
Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension (2002) 1.03
Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation (2002) 0.93
Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab (1992) 0.93
Polymorphisms of the vitamin D receptor gene and stress fractures. Horm Metab Res (2009) 0.92
Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed Proc (1986) 0.92
Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail (2010) 0.92
Vitamin D and stress fracture: the contribution of vitamin D receptor gene polymorphisms. Nutr Rev (2010) 0.88
Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism? Horm Metab Res (2010) 0.86
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation (2003) 3.49
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Health benefits of gastric bypass surgery after 6 years. JAMA (2012) 3.10
Medical student perceptions of the scope of plastic and reconstructive surgery. Ann Plast Surg (2013) 2.85
Melatonin secretion and the incidence of type 2 diabetes. JAMA (2013) 2.65
A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Hum Genet (2004) 2.53
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Uric acid and the development of hypertension: the normative aging study. Hypertension (2006) 2.45
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
Chocolate consumption is inversely associated with prevalent coronary heart disease: the National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr (2010) 2.40
Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension (2004) 2.36
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation (2004) 2.35
Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology (2014) 2.17
Marital status, dipping and nocturnal blood pressure: results from the Dietary Approaches to Stop Hypertension trial. J Hypertens (2014) 2.09
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05
Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation (2005) 2.03
Sleep duration and risk for hypertension in women: results from the nurses' health study. Am J Hypertens (2013) 2.03
Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension (2007) 1.98
Vitamin D and hypertension: current evidence and future directions. Hypertension (2010) 1.95
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics (2004) 1.95
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans. Hypertension (2010) 1.94
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension (2007) 1.93
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension (2006) 1.91
Using regular expressions to abstract blood pressure and treatment intensification information from the text of physician notes. J Am Med Inform Assoc (2006) 1.89
The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci (2005) 1.87
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension (2011) 1.85
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes (2004) 1.85
A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol (2008) 1.85
Association of the FTO gene with BMI. Obesity (Silver Spring) (2008) 1.79
Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest (2012) 1.78
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab (2007) 1.78
Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol (2012) 1.77
Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension (2009) 1.75
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int (2011) 1.74
Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation (2007) 1.73
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation (2008) 1.73
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension (2006) 1.72
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
50th anniversary of aldosterone. J Clin Endocrinol Metab (2003) 1.70
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (2010) 1.69
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc (2002) 1.69
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. Ann Surg (2016) 1.66
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics (2013) 1.65
Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) (2009) 1.64
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int (2012) 1.60
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. J Clin Endocrinol Metab (2002) 1.60
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.58
Determinants of plasma parathyroid hormone levels in young women. Calcif Tissue Int (2010) 1.58
Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology (2006) 1.58
Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. Crit Care Med (2012) 1.58
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care (2008) 1.58
Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med (2013) 1.57
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens (2011) 1.57
Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care (2011) 1.56
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol (2006) 1.56
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension (2013) 1.55
Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol (2010) 1.54
Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery. Contemp Clin Trials (2005) 1.53
Primary care management of chronic kidney disease. J Gen Intern Med (2010) 1.52
The epithelial sodium channel γ-subunit gene and blood pressure: family based association, renal gene expression, and physiological analyses. Hypertension (2011) 1.50
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circ Cardiovasc Genet (2015) 1.50
Aldosterone--villain or bystander? N Engl J Med (2004) 1.49
Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. Menopause (2008) 1.49
Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr (2009) 1.49
Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: the Hypertension Genetic Epidemiology Network study. J Hypertens (2005) 1.49
Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet (2011) 1.49
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. Hypertension (2005) 1.47
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol (2004) 1.44
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol (2005) 1.44
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes. Acad Med (2008) 1.42
Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care (2011) 1.42
Policies on donation after cardiac death at children's hospitals: a mixed-methods analysis of variation. JAMA (2009) 1.40
Concern microRNA-218 Inhibits Oxygen-induced Retinal Neovascularization via Reducing the Expression of Roundabout 1. Chin Med J (Engl) (2016) 1.38
A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet Genomics (2012) 1.35
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology (2006) 1.34
Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens (2003) 1.34
Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol (2005) 1.31
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet (2005) 1.29
Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) (2009) 1.29